US6045785A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Deodorizing preparations
Assignee: BASF Personal Care and Nutrition GmbH
•
Filing: 1997-10-08
•
Granted: 2000-04-04
•
Expires: 2017-10-08
Abstract
Abstract PCT No. PCT/EP97/05523 Sec. 371 Date Apr. 16, 1999 Sec. 102(e) Date Apr. 16, 1999 PCT Filed Oct. 8, 1997 PCT Pub. No. WO98/17241 PCT Pub. Date Apr. 30, 1998The invention relates to novel deodorizing preparations with increased synergetic performance containing (a) sterol sulfate, (b1) aluminum chlorhydrate, (b2) esterase inhibitors and/or (b3) bactericidal or bacteriostatic active substances.
Inventors
- 👤 Rolf Wachter
- 👤 Holger Tesmann
- 👤 Ansgar Behler
- 👤 Karl-Heinz Maurer
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-03 13:08
CPC Classifications
A; A61; A61Q; A61Q15/00; A61K; A61K8/00; A61K8/18; A61K8/19; A61K8/26; A61K8/30; A61K8/33; A61K8/37; A61K8/63; A61K8/72; A61K8/73; A61K8/736; A61P; A61P17/00; A61K2800/00; A61K2800/74; A61K2800/78; A61K2800/782
Claims Analysis
Total Claims: 17
Claim 1
Independent Claim
23 words
A deodorizing formulation comprising: (a) a sterol sulfate; (b) aluminum chlorohydrate; and (c) an esterase inhibitor, a bactericidal agent, or a bacteriostatic agent.
Claim 2
Dependent Claim
23 words
A deodorizing formulation comprising: (a) a sterol sulfate; (b) aluminum chlorohydrate; and (c) an esterase inhibitor, a bactericidal agent, or a bacteriostatic agent.
Claim 3
Dependent Claim
14 words
A formulation according to claim 1, wherein the sterol sulfate is a phytosterol sulfate.
Claim 4
Dependent Claim
14 words
A formulation according to claim 1, wherein the esterase inhibitor is a trialkyl citrate.
Claim 5
Dependent Claim
17 words
A formulation according to claim 1, wherein the bactericidal agent or the bacteriostatic agent is a chitosan.
Claim 6
Dependent Claim
57 words
A deodorizing formulation comprising: (a) 0.01% to 50% by weight of a sterol sulfate; (b) 1.0% to 50% by weight of aluminum chlorohydrate; (c) 0.01% to 20% by weight of an esterase inhibitor; and (d) 0.01% to 5% by weight of a bactericidal or bacteriostatic agent, said percents based on the total solids weight of the formulation.
Claim 7
Dependent Claim
57 words
A deodorizing formulation comprising: (a) 0.01% to 50% by weight of a sterol sulfate; (b) 1.0% to 50% by weight of aluminum chlorohydrate; (c) 0.01% to 20% by weight of an esterase inhibitor; and (d) 0.01% to 5% by weight of a bactericidal or bacteriostatic agent, said percents based on the total solids weight of the formulation.
Claim 8
Dependent Claim
49 words
A formulation according to claim 5, comprising: (a) 0.1% to 5% by weight of a sterol sulfate; (b) 10% to 50% by weight of aluminum chlorohydrate; (c) 1% to 5% by weight of an esterase inhibitor; and (d) 0.1% to 1% by weight of a bactericidal or bacteriostatic agent.
Claim 9
Dependent Claim
27 words
A formulation according to claim 5, wherein the sterol sulfate is derived from a sterol selected from the group consisting of phytosterols, zoosterols, lanosterols, spongosterols, and stellasterols.
Claim 10
Dependent Claim
26 words
A formulation according to claim 7, wherein the sterol sulfate is derived from a phytosterol selected from the group consisting of ergosterols, campesterols, stigmasterols, and sitosterols.
Claim 11
Dependent Claim
20 words
A formulation according to claim 5, wherein the aluminum chlorohydrate has the formula [Al 2 (OH) 5 Cl].2.5H 2 O.
Claim 12
Dependent Claim
30 words
A formulation according to claim 5, wherein the esterase inhibitor is selected from the group consisting of trialkyl citrates, dicarboxylic acids and esters thereof, and hydroxycarboxylic acids and esters thereof.
Claim 13
Dependent Claim
62 words
A formulation according to claim 10, wherein the esterase inhibitor is selected from the group consisting of trimethyl citrate, tripropyl citrate, tributyl citrate, triethyl citrate, glutaric acid, glutaric acid monoethyl ester, glutaric acid diethyl ester, adipic acid, adipic acid monoethyl ester, adipic acid diethyl ester, malonic acid, malonic acid diethyl ester, citric acid, malic acid, tartaric acid, and tartaric acid diethyl ester.
Claim 14
Dependent Claim
23 words
A formulation according to claim 5, wherein the bactericidal or bacteriostatic agent is selected from the group consisting of chitosan, phenoxyethanol, and chloro-2-(2,4-dichlorophenoxy)-phenol.
Claim 15
Dependent Claim
131 words
A deodorizing formulation comprising: (a) 0.01% to 50% by weight of a sterol sulfate; (b) 1.0% to 50% by weight of aluminum chlorohydrate; and (c) 0.01% to 20% by weight of an esterase inhibitor or 0.01% to 5% by weight of a bactericidal or bacteriostatic agent, said percents based on the total solids weight of the formulation, wherein the sterol sulfate is derived from a sterol selected from the group consisting of phytosterols, zoosterols, lanosterols, spongosterols, and stellasterols, the aluminum chlorohydrate has the formula [Al 2 (OH) 5 Cl].2.5H 2 O, the esterase inhibitor is selected from the group consisting of trialkyl citrates, dicarboxylic acids and esters thereof, and hydroxycarboxylic acids and esters thereof, and the bactericidal or bacteriostatic agent is selected from the group consisting of chitosan, phenoxyethanol, and chloro-2-(2,4-dichlorophenoxy)-phenol.
Claim 16
Dependent Claim
131 words
A deodorizing formulation comprising: (a) 0.01% to 50% by weight of a sterol sulfate; (b) 1.0% to 50% by weight of aluminum chlorohydrate; and (c) 0.01% to 20% by weight of an esterase inhibitor or 0.01% to 5% by weight of a bactericidal or bacteriostatic agent, said percents based on the total solids weight of the formulation, wherein the sterol sulfate is derived from a sterol selected from the group consisting of phytosterols, zoosterols, lanosterols, spongosterols, and stellasterols, the aluminum chlorohydrate has the formula [Al 2 (OH) 5 Cl].2.5H 2 O, the esterase inhibitor is selected from the group consisting of trialkyl citrates, dicarboxylic acids and esters thereof, and hydroxycarboxylic acids and esters thereof, and the bactericidal or bacteriostatic agent is selected from the group consisting of chitosan, phenoxyethanol, and chloro-2-(2,4-dichlorophenoxy)-phenol.
Claim 17
Dependent Claim
82 words
A formulation according to claim 13, wherein the sterol sulfate is derived from a phytosterol selected from the group consisting of ergosterols, campesterols, stigmasterols, and sitosterols, and the esterase inhibitor is selected from the group consisting of trimethyl citrate, tripropyl citrate, tributyl citrate, triethyl citrate, glutaric acid, glutaric acid monoethyl ester, glutaric acid diethyl ester, adipic acid, adipic acid monoethyl ester, adipic acid diethyl ester, malonic acid, malonic acid diethyl ester, citric acid, malic acid, tartaric acid, and tartaric acid diethyl ester.
References Cited (Backward Citations)
US4450151A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2003-04-04 | 2003-10-04 | 2004-04-04 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2007-04-04 | 2007-10-04 | 2008-04-04 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2011-04-04 | 2011-10-04 | 2012-04-04 | $7700.00 | Window Closed / Lapsed |